ProPublica: What a $2 Million Per Dose Gene Therapy Reveals About Drug Pricing

“Drug companies charge whatever they think they can get away with,” said David Mitchell, the founder of Patients For Affordable Drugs. “And every time the benchmark moves up, they think, ‘Well, we can get away with more.’